Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists breed pigs resistant to deadly virus
Pig
PRRS virus causes reproductive failure and can also cause respiratory tract illness in young pigs.

Discovery could have enormous implications for pig producers

Scientists at the University of Missouri have bred the first pigs which are resistant porcine reproductive and respiratory syndrome (PRRS) virus.

Using gene editing techniques the researchers were able to develop a pig that lacked the protein CD163, which is necessary for the PRRS virus to infect the pig's cells and cause disease.

Recent results show the gene-edited animals are resistant to infection from the virus. They do not get ill and have no signs of virus in their bodies. Kristin Whitworth, co-author of the study, explains:

“We edited the gene that makes the CD163 protein so the pigs could no longer produce it.

“We then infected these pigs and control pigs; the pigs without CD163 never got sick. This discovery could have enormous implications for pig producers and the food industry throughout the world.”

While the pigs that didn't produce the CD163 didn't get sick,the researchers noted no other changes in their development, compared to pigs that produce the protein.

Following these promising early results, the University of Missouri has signed an exclusive global licensing agreement for future commercialisation of virus resistant pigs with the Genus, plc.

If the development stage is successful, the commercial partner will seek any necessary approvals and registration from governments before a wider market release.

Welcoming the news, professor Bruce Whitelaw, head of division of developmental biology at the Roslin Institute said: “Although the research is still at an early stage, this paper points to what can be achieved using the new genome editing technology and could be a game changer for the pig industry.

"It has the potential to benefit the entire pork food chain from the farmer through to the consumer.”

Gene-editing involves modifying individual letters of an animal's genetic code. It is different from traditional GM techniques, because no new information is inserted into the DNA.

PRRS virus causes reproductive failure and can also cause respiratory tract illness in young pigs. There is currently no cure or adequate treatment.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.